Market revenue in 2023 | USD 6,835.9 million |
Market revenue in 2030 | USD 12,866.0 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Drug Eluting Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 22.76% in 2023. Horizon Databook has segmented the Germany drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Germany’s healthcare system is considered the pioneering one in public health support, with the oldest national social health insurance system. Schemes such as Statutory Health Insurance (SHI) are strengthening healthcare infrastructure, facilitating people to undergo advanced treatment, which is expected to increase the demand for drug-device combination products.
The drug device combination products market in Germany is dynamic and competitive, with several major players competing for revenue share. Germany has one of the oldest populations in the world. Old age is one of the risk factors for several cardiac and ophthalmic disorders.
Hence, the increase in the prevalence of cardiac and ophthalmic disorders in the geriatric population is expected to boost the market. Moreover, the demand for drug-device combination products in Germany is expected to grow due to the rising number of respiratory failure cases and surgical procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Germany drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account